Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting ; volume:15 ; number:1 ; day:28 ; month:2 ; year:2024 ; pages:1-12 ; date:12.2024
Nature Communications ; 15, Heft 1 (28.2.2024), 1-12, 12.2024

Creator: Kubota, Yasuo
Gu, Xiaorong
Terkawi, Laila
Bodo, Juraj
Przychodzen, Bartlomiej P.
Awada, Hussein
Williams, Nakisha
Gurnari, Carmelo
Kawashima, Naomi
Aly, Mai
Durmaz, Arda
Mori, Minako
Ponvilawan, Ben
Kewan, Tariq
Bahaj, Waled
Meggendorfer, Manja
Jha, Babal K.
Visconte, Valeria
Rogers, Heesun J.
Haferlach, Torsten
Maciejewski, Jaroslaw P.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-024-46134-w

URN: urn:nbn:de:101:1-2405061032388.673803241737

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kubota, Yasuo
Gu, Xiaorong
Terkawi, Laila
Bodo, Juraj
Przychodzen, Bartlomiej P.
Awada, Hussein
Williams, Nakisha
Gurnari, Carmelo
Kawashima, Naomi
Aly, Mai
Durmaz, Arda
Mori, Minako
Ponvilawan, Ben
Kewan, Tariq
Bahaj, Waled
Meggendorfer, Manja
Jha, Babal K.
Visconte, Valeria
Rogers, Heesun J.
Haferlach, Torsten
Maciejewski, Jaroslaw P.
SpringerLink (Online service)

Other Objects (12)

Multiparameter prediction of myeloid neoplasia risk

Hochschulschrift

Molecular pathogenesis of myeloid neoplasia and therapeutic implications : = Molekulare Pathogenese von myeloischen Neoplasien und deren therapeutische Beeinflussbarkeit

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

Aufsatzsammlung

Intraepithelial neoplasia

Multiparameter prediction of myeloid neoplasia risk

Hochschulschrift

Molecular pathogenesis of myeloid neoplasia and therapeutic implications : = Molekulare Pathogenese von myeloischen Neoplasien und deren therapeutische Beeinflussbarkeit

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

Aufsatzsammlung

Intraepithelial neoplasia

Multiparameter prediction of myeloid neoplasia risk

Hochschulschrift

Molecular pathogenesis of myeloid neoplasia and therapeutic implications : = Molekulare Pathogenese von myeloischen Neoplasien und deren therapeutische Beeinflussbarkeit

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

Aufsatzsammlung

Intraepithelial neoplasia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Multiparameter prediction of myeloid neoplasia risk

Molecular pathogenesis of myeloid neoplasia and therapeutic implications : = Molekulare Pathogenese von myeloischen Neoplasien und deren therapeutische Beeinflussbarkeit

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

Intraepithelial neoplasia

Multiparameter prediction of myeloid neoplasia risk

Molecular pathogenesis of myeloid neoplasia and therapeutic implications : = Molekulare Pathogenese von myeloischen Neoplasien und deren therapeutische Beeinflussbarkeit

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

Intraepithelial neoplasia

Multiparameter prediction of myeloid neoplasia risk

Molecular pathogenesis of myeloid neoplasia and therapeutic implications : = Molekulare Pathogenese von myeloischen Neoplasien und deren therapeutische Beeinflussbarkeit

Molecular patterns identify distinct subclasses of myeloid neoplasia

Author Correction: Multiparameter prediction of myeloid neoplasia risk

Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia

Landscape of biallelic DNMT3A mutant myeloid neoplasms

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia

Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia

Intraepithelial neoplasia

Related objects

Reset password